ATE256753T1 - Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten - Google Patents

Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten

Info

Publication number
ATE256753T1
ATE256753T1 AT00945124T AT00945124T ATE256753T1 AT E256753 T1 ATE256753 T1 AT E256753T1 AT 00945124 T AT00945124 T AT 00945124T AT 00945124 T AT00945124 T AT 00945124T AT E256753 T1 ATE256753 T1 AT E256753T1
Authority
AT
Austria
Prior art keywords
sequence
base pair
primers
sequences
respect
Prior art date
Application number
AT00945124T
Other languages
English (en)
Inventor
Kent D Taylor
Maren Scheuner
Jerome Rotter
Huiying Yang
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center
Application granted granted Critical
Publication of ATE256753T1 publication Critical patent/ATE256753T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00945124T 1999-07-02 2000-06-30 Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten ATE256753T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/347,114 US6297014B1 (en) 1999-07-02 1999-07-02 Genetic test to determine non-responsiveness to statin drug treatment
PCT/US2000/018308 WO2001002606A2 (en) 1999-07-02 2000-06-30 Genetic test to determine non-responsiveness to statin drug treatment

Publications (1)

Publication Number Publication Date
ATE256753T1 true ATE256753T1 (de) 2004-01-15

Family

ID=23362384

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03028652T ATE513922T1 (de) 1999-07-02 2000-06-30 Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten
AT00945124T ATE256753T1 (de) 1999-07-02 2000-06-30 Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03028652T ATE513922T1 (de) 1999-07-02 2000-06-30 Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten

Country Status (9)

Country Link
US (2) US6297014B1 (de)
EP (2) EP1228241B1 (de)
AT (2) ATE513922T1 (de)
AU (1) AU5911100A (de)
DE (1) DE60007352T2 (de)
DK (1) DK1228241T3 (de)
ES (1) ES2211568T3 (de)
PT (1) PT1228241E (de)
WO (1) WO2001002606A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040161765A1 (en) * 2001-04-13 2004-08-19 Dietz Harry C. Methods and compositions for identifying disease genes using nonsense-mediated decay inhibition
US20020164598A1 (en) * 2001-05-03 2002-11-07 Ihc Health Services, Inc. Method for evaluating and applying an individual's genetic characteristics to determine response to cardiovascular medication therapy
JP2005508612A (ja) * 2001-06-29 2005-04-07 ディーエヌエープリント ジェノミクス インコーポレーティッド スタチンに対する応答を推定するための組成物および方法
US6723527B2 (en) * 2001-10-26 2004-04-20 Board Of Regents, The University Of Texas System Methods for determining toxicity reversing agents
EP1539790A4 (de) * 2002-06-14 2006-08-09 Cedars Sinai Medical Center Auf dem haplotyp basierendes verfahren zur genetischen analyse zur bestimmung des risikos, insulinresistenz, koronare herzkrankheit und andere phenotypen zu entwickeln
US8178294B2 (en) * 2002-06-14 2012-05-15 Cedars-Sinai Medical Center Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes
US20040110241A1 (en) * 2002-12-06 2004-06-10 Segal Mark S. Materials and methods for monitoring vascular endothelial function
WO2004069867A2 (en) * 2003-02-03 2004-08-19 Bayer Healthcare Ag Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
US8688385B2 (en) * 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
JP5348840B2 (ja) 2003-02-20 2013-11-20 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 薬物を選択する方法
EP1704253A1 (de) * 2004-01-15 2006-09-27 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Zur erkennung von thrombophilie entwickeltes verfahren (mert)
EP1745129B1 (de) 2004-04-16 2009-04-15 Idexx Laboratories, Inc. Antikörper gegen hundepankreaslipase
JP2009523006A (ja) * 2004-05-07 2009-06-18 アプレラ コーポレイション 脈管疾患に関連する遺伝的多型、その検出方法および使用
JP2009517186A (ja) * 2005-11-29 2009-04-30 チルドレンズ ホスピタル メディカル センター 薬物選択及び投薬の最適化及び個別化
US20100130600A1 (en) * 2007-03-30 2010-05-27 Cedars-Sinai Medical Center Lipoprotein lipase and its effect on statin treatments
WO2009052179A2 (en) * 2007-10-15 2009-04-23 Idexx Laboratories, Inc. Feline pancreatic lipase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
CA2013317A1 (en) 1989-04-17 1990-10-17 Fred T. Oakes Diagnostic kit, primer composition and their use for replication or detection of nucleic acids

Also Published As

Publication number Publication date
EP1408121A2 (de) 2004-04-14
WO2001002606A2 (en) 2001-01-11
DK1228241T3 (da) 2004-04-19
DE60007352D1 (de) 2004-01-29
US6297014B1 (en) 2001-10-02
DE60007352T2 (de) 2004-09-02
PT1228241E (pt) 2004-05-31
ES2211568T3 (es) 2004-07-16
AU5911100A (en) 2001-01-22
EP1408121B1 (de) 2011-06-22
ATE513922T1 (de) 2011-07-15
US20020106657A1 (en) 2002-08-08
WO2001002606A3 (en) 2002-06-13
EP1228241A2 (de) 2002-08-07
EP1408121A3 (de) 2007-06-06
EP1228241B1 (de) 2003-12-17

Similar Documents

Publication Publication Date Title
ATE513922T1 (de) Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten
Bellone et al. Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus)
Nishisho et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients
Gécz et al. FMR2 expression in families with FRAXE mental retardation
WO2001057274A8 (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
ATE360808T1 (de) Unabhängiges gerät zur extraktion, amplifikation und nachweis von nukleinsäuren
ATE251222T1 (de) Verfahren zur bestimung von ki-ras mutationen und dieses leistender testsatz
DE3853678D1 (de) Verfahren zum nachweis des karzinogenen menschlichen papillomavirus.
Ahn et al. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis
Steichen-Gersdorf et al. Deletion mapping on chromosome 17p in medulloblastoma
Franco et al. The prevalence of factor V Arg306→ Thr (factor V Cambridge) and factor V Arg306→ Gly mutations in different human populations
CA2382848A1 (en) Diagnostics and therapeutics for osteoporosis
ES2252159T3 (es) Polimorfismos en el gen humano del transportador de anion organico c (oatp-c).
DE69705936D1 (de) Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose
Shi et al. Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-γ-independent mechanisms
DE60136746D1 (de) Oligonucleotide zur markierung von oligonukleotidsonden und proteine
ATE195152T1 (de) Nukleotidsonden
NZ518458A (en) Isolate DNA polymerase lambda and uses thereof
Johnson et al. A 1.5-Mb contig within the cat eye syndrome critical region at human chromosome 22q11. 2
Brand et al. Identification of two polymorphisms in the early growth response protein-1 gene: possible association with lipid variables
Proudnikov et al. Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history
DE60029939D1 (de) Diagnosisverfahren für whipples krankheit
MXPA97000542A (es) Sondas de adn especificas para identificacion delas especies taenia solium y taenia saginata.
WO2001018240A3 (en) Diagnostic and therapeutic methods in autoimmune disease
Fujiwara et al. Prevention of cross-contamination during sampling procedure in molecular detection for cancer micrometastasis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1228241

Country of ref document: EP

REN Ceased due to non-payment of the annual fee